A prospective study of dose-adjusted (DA) epoch with rituximab in adults with newly diagnosed burkitt lymphoma: A regimen with high efficacy and low toxicity
ANNALS OF ONCOLOGY(2008)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ANNALS OF ONCOLOGY(2008)